You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intestinal bile acid transport inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fecal Bile Acid Profile and Intestinal Flora With Chronic

Recruiting
  • Radiation Enteritis
    • Xi'an, Shaanxi, China
      Xijing Hosipital of Digestive Disease
    Feb 19, 2023

    Irritable Bowel Syndrome-bile Acid Diarrhea Trial in Rochester (BB01)

    Not yet recruiting
    • Irritable Bowel Syndrome-bile Acid Diarrhea
    • BB01
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    Aug 31, 2023

    Bile Acids in Acute Insulin Resistance

    Recruiting
    • PI3K Gene Mutation
    • +4 more
    • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
    • New York, New York
      Columbia University Medical Center
    Oct 6, 2022

    Functional Constipation Trial in Rochester (A3309, )

    Completed
    Has Results
    • Functional Constipation
    • Rochester, Minnesota
      Mayo Clinic
    Sep 3, 2020

    Human Microbiome Trial in Seoul (Cholestyramine Resin)

    Completed
    • Human Microbiome
    • Cholestyramine Resin
    • Seoul, Korea, Republic of
      Seoul National University Bundang Hospital
    Mar 15, 2021

    Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)

    Recruiting
    • Coronary Artery Disease
    • +3 more
    • Seoul, Korea, Republic of
      Asan Medical Center
    Mar 6, 2022

    Alagille Syndrome Trial in Birmingham, Leeds, London (LUM001 (Maralixibat))

    Completed
    Has Results
    • Alagille Syndrome
    • LUM001 (Maralixibat)
    • Birmingham, West Midlands, United Kingdom
    • +2 more
    Nov 17, 2021

    Healthy Trial in Mexico City (High-protein diet)

    Not yet recruiting
    • Healthy
    • High-protein diet
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Jun 7, 2023

    FGF19 in Obstructive Cholestasis: "Unveil the Signal"

    Recruiting
    • Cholestasis
    • +4 more
    • Biospecimen sampling
    • Aachen, Germany
      RWTH Aachen
    Feb 6, 2023

    Primary Biliary Cholangitis Trial in Beijing (Obeticholic Acid Tablets(OCA), UDCA, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Obeticholic Acid Tablets（OCA）
    • +2 more
    • Beijing, China
      Beijing Friendship Hospital
    Jul 7, 2022

    Host and Microbial Mechanisms and Druggable Targets for

    Recruiting
    • Inflammatory Bowel Diseases
    • Primary Sclerosing Cholangitis
    • Oral Vancomycin
    • Birmingham, United Kingdom
      University Hospitals Birmingham NHS Foundation Trust
    May 27, 2022

    Colorectal Cancer, Diet Habit Trial in Chicago (Med, WL)

    Recruiting
    • Colorectal Cancer
    • Diet Habit
    • Med
    • WL
    • Chicago, Illinois
      University of Illinois at Chicago
    Jan 10, 2023

    SEPSIS, MALNUTRITION, CHILD Trial in Worldwide (Pancreatic Enzyme, Ursodeoxycholic acid)

    Not yet recruiting
    • SEPSIS
    • MALNUTRITION, CHILD
    • Pancreatic Enzyme
    • Ursodeoxycholic acid
    • Dhaka, Bangladesh
    • +3 more
    Sep 1, 2020

    Secondary Sclerosis Cholangitis Prospective

    Recruiting
    • Secondary Sclerosis Cholangitis in Critically Ill Patients
      • Graz, Austria
        Medical University Graz
      Sep 26, 2022

      Alagille Syndrome Trial in Worldwide (LUM001 (Maralixibat), Placebo)

      Completed
      Has Results
      • Alagille Syndrome
      • LUM001 (Maralixibat)
      • Placebo
      • Westmead, New South Wales, Australia
      • +8 more
      Jun 23, 2021

      Primary Biliary Cirrhosis Trial in Aarhus (Obeticholic acid, Placebos)

      Completed
      • Primary Biliary Cirrhosis
      • Obeticholic acid
      • Placebos
      • Aarhus, Denmark
        Susanne Keiding
      Oct 31, 2019

      Primary Sclerosing Cholangitis, Autoimmune Hepatitis, Overlap Syndrome Trial in Brussel (Metronidazole)

      Completed
      • Primary Sclerosing Cholangitis
      • +2 more
      • Brussel, Bruxelles, Belgium
        Cliniques Universitaires Saint-Luc - Université Catholique de Lo
      Aug 4, 2022

      Obesity, Inflammation Trial in Urbana (Walnuts, Walnut Oil, Control)

      Recruiting
      • Obesity
      • Inflammation
      • Walnuts
      • +2 more
      • Urbana, Illinois
        Hannah Holscher
      Jun 28, 2022

      Cholestatic Liver Disease Trial in Worldwide (Maralixibat)

      Active, not recruiting
      • Cholestatic Liver Disease
      • Los Angeles, California
      • +16 more
      Jan 19, 2022

      Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

      Recruiting
      • Advanced Hepatocellular Carcinoma
      • Bifidobacterium Bifidum Oral Product
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-Sen University
      Nov 16, 2022

      Colon Adenocarcinoma, Diarrhea Trial in Aarhus (Antibiotics, Bile Acid Binder)

      Completed
      • Colon Adenocarcinoma
      • Diarrhea
      • Aarhus, Denmark
        Department of Hepatology and Gastroenterology, Aarhus University
      Aug 31, 2021

      Intestinal Transit Trial in Plymouth (Loperamide, Senna)

      Active, not recruiting
      • Intestinal Transit
      • Plymouth, United Kingdom
        Derriford Hospital
      Oct 7, 2021

      Gastric Intestinal Metaplasia Trial in Xi'an (Metformin, Folate)

      Recruiting
      • Gastric Intestinal Metaplasia
      • Xi'an, Shaanxi, China
      • +1 more
      Jan 29, 2023

      Insulin Resistance Trial in Poznan (the group GS (probiotic), the group GP ())

      Completed
      • Insulin Resistance
      • the group GS (probiotic)
      • the group GP (placebo)
      • Poznań, Poland
        Poznan University of Physical Education
      Oct 13, 2023

      Barrett Esophagus Trial (Obeticholic Acid, Placebo Administration)

      Not yet recruiting
      • Barrett Esophagus
      • Obeticholic Acid
      • Placebo Administration
      • (no location specified)
      Oct 13, 2022